سامانه پژوهشی – مقایسه تأثیر درمان های نگهدارنده متادون و بوپرنورفین بر عملکردهای شناختی نقش تعدیل …

Czuchry, M., & Dansereau, DF. (2003). Cognitive skills training: impact on drug abuse counseling and readiness for treatment. Journal Drug Alcohol Abuse; 29(1): 1-18.
Comer, S.D., Walker, E.A., & Collins, E.D.(2005). Buprenophine/naloxone reduces the reinforcing and subjective effects of heroin in heroin dependent volunteers. Psychopharmacology (Berl), 181, 664-75.
Connock,M.,Juarez-Garcia,A.,Jowett,S.,Frew,E.,Liu,Z.,Taylor,RJ.,…& FrySmith,A.(2007). Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.Health Technology Assessment,11,9.
Comer, S.D., Walker, E.A.,& Collins, E.D.(2005).Buprenorphine/naloxone reduces the reinforcing and subjective effects of heroin in heroin dependent volunteers. Psychopharmacology (Berl) ,۱۸۱, ۶۶۴-۷۵٫
De Maeyer, J., Vanderplasschen ,W., Lammertyn, J., van Nieuwenhuizen, C., Sabbe ,B.,& Broekaert, E.(2011). Current qualityof life and its deter -minants among opiate-dependent individuals five years after starting methadone treatment. Qual Life Res, 20,139–۱۵۰٫
Darke, S., Sims, J., McDonald, S., & Wickes, W. (2000). Cognitive impairment among methadone maintenance patients. Addiction, ۹۵, ۶۸۷-۶۹۵٫
Davis, P. E., Liddiard, H., & McMillan, T. M. (2002). Neuropsychological deficits and opiate abuse. Drug and Alcohol Dependence, ۶۷,۱۰۵-۱۰۸٫
Dole – Nyswander, M., & Kreek, M.(1966). Narcotic blockade. Arch Intern Med, 118: 304-309.
Ford, C., Morton, S., Lintzeris, N., Bury, J., & Gerada. C. (2004). Guidance for the Use of Buprenorphine for the Treatment of Opioid Dependence in Primary Care. 2nd ed. London, UK: RCGP Drug and Alcohol Misuse Training Programme . (www.rcgp.org.uk/pdf/drug_buprenorphine.pdf)
Giacomuzzi, SM., Thill, C., Riemer ,Y., Garber, K., & Ertl. M. (2008). Buprenorphine-and methadone maintenance treatment: influence on aspects of cognitive and memory performance.Open Addiction journal, 1,5–۶٫
Gerra, G., Borella, F., Zaimovic, A., Moi, G., Bussandri, M., Bubici, C., & Bertacca, S.(2004). Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome. Drug Alcohol Depend, 75(1): 37–۴۵٫
Harris, DS., Mendelson, JE., Lin, ET.,Upton, RA.,& Jones, RT.(2004). Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone – Lack of dose proportionality. Clin Pharmacokinet; 43: 329-40.
Kakko, J., Svanborg, K.D., Kreek, M.J.,& Heilig, M.(2003). 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden, a randomised, placebo-controlled trial. Lancet, 361(9358): 662–۸٫
kulesza,k. (2006).Attention-Defict hyperactivity disorder and executive function: potential vulnerability for Bully/ victimization Behavior. A Doctoral Dissertation,The university of texas south western medical center at dallas.
Ling, W., Charuvastra, C., Kaim, S.C.,& Klett, C.J.(1976). Methady1 acetate and methadone as maintenance treatments for heroin addicts. a veterans administration cooperative study. Arch Gen Psychiatry , ۳۳(۶): ۷۰۹–۲۰٫
Layson-Wolf, C., Goode, J.V., & Small, R.E.(2002). Clinical use of methadone. Journal Pain Palliat Care Pharmacother ,۱۶(۱): ۲۹–۵۹٫
Lyvers, M., & Yakimoff, M.(2003). Neuropsychological correlates of opioid dependence and withdrawal. Addict Behav; 28(3): 605-11.
Mattick, R.P., Breen, C., Kimber, J.,& Davioli, M.(2004). Methadone maintenance therapy versus no opioid treplacement therapy for opioid dependence (Cochrane Review). The Cochrane Library, ۴٫ Chichester, Wiley.
McLellan, A.G., Arndt, I.O., Metzger, D.S., Woody, G.E.,& O’Brien, C.P.(1993). The effects of psychosocial services in substance abuse treatment. Journal Am Med Assoc, 269: 1953–۹٫
McNicolas, L., (2004). Clinical Guidelines for the use of Buprenorphine in the Treatment of Opioid Addiction. U.S. Department of Health and Human Services.
Novick, D.M., Joseph, H., Croxson ,T.S., et al.(1990). Absence of antibody to Human Immunodeficiency Virus in long-term, socially rehabilitated methadone maintenance patients. Archives of Internal Medicine, 150:97-99.
Petitjean, S., Stohler, R., Deglon, J.J., Livoti, S., Waldvogel, D., Uehlinger, C.,& Ladewig,D.(2001). Double-blind randomized trial of buprenorphine and methadone in opioid dependence. Drug Alcohol Depend , ۶۲(۱): ۹۷–۱۰۴٫
Pirastu, R., Fais, R., Messina, M., Bini, V., Spiga, S., Falconieri, D.,& Diana, M.(2006). Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug Alcohol Depend, 83:163–۱۶۸٫
Paulus, MP., Hozack, NE., Zauscher, BE., Frank, L., Brown, GG.,& Braff, DL.(2002). Behavioral and functional neuroimaging evidence for prefrontal dysfunction in methamphetamine-dependent subjects. Neuropsychopharmacology; 26(1): 53-6.
Poser, S., Poser, W., Medikamente – Missbrauch & Abhängigkeit (1996). Entstehung. Verlauf. Behandlung(Pharmaceuticals and dependence: onset, course, treatment). Stuttgart, Thieme.
Robinson, T. E., & Berridge, K. C. (2003). Addiction. Annual Review of Psychology,54, 25–۵۳٫
Rapeli, P., Kivisaari, R., Autti, T., Kahkonen, S., Puuskari, V.,… & Kalska, H.(2006). Cognitive function during early abstinence from opioid dependence: a comparison to age, gender, and verbal intelligence matched controls. BMC Psychiatry ۶:۹ Feb 24.
Rapeli, P., Fabritius, C., Alho, H., Salaspuro, M., Wahlbeck, K & Kalska, H.(2007).Methadone vs buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performancerelative to healthy controls. BMC Clin Pharmacol; 7: 5.
Rapeli, P., Carola Fabritius, C., Kalska, H& Alho, H.(2009). Memory function in opioid dependent patients treated with methadone or buprenorphine along with benzodiazepine:longitudinal change in comparison to healthy individuals. Substance Abuse Treatment, Prevention, and Policy. 4:6. doi:10.1186/1747-597X-4-6
Rapeli, P., Carola Fabritius, C., Kalska, H& Alho, H.(2011). Cognitive functioning in opioid dependentpatients treated with buprenorphine, methadone,and other psychoactive medications: stability and correlates. BMC Clinical Pharmacology, 11:13.
Rapeli, P., Carola Fabritius, C., Kalska, H& Alho, H.(2012).Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study. Substance Abuse Treatment, Prevention, and Policy, 7:45.
San ,L., Cami, J., Peri, J.M., Mata, R.,& Porta, M.(1990). Efficacy of clonidine, guanfacine and methadone in the rapid detoxification of heroin addicts: a controlled clinical trial. Br Journal Addict ۸۵(۱): ۱۴۱–۷٫